← Back to Search

Other

Educational Sessions for Schizophrenia (CHAMPION Trial)

N/A

Waitlist Available

Research Sponsored by University of Maryland, Baltimore

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Between the ages of 22 and 85 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and endpoint changes after 12 month intervention

Awards & highlights

CHAMPION Trial Summary

This trial will test the effectiveness of an ECHO-based intervention, CHAMPION, for improving the use of clozapine in people eligible for clozapine. The sessions will include active dissemination of knowledge and information by an expert "hub" followed by clozapine case presentations and vignettes submitted by the "spokes".

Who is the study for?

This trial is for prescribers and clinical team members in Maryland, aged 22-85, who have experience prescribing antipsychotics. They must be willing to engage in educational sessions aimed at improving clozapine use for schizophrenia treatment. Participants need to commit to pre- and post-testing and try attending the CHAMPION sessions.Check my eligibility

What is being tested?

The study tests an ECHO-based intervention called 'CHAMPION' designed to enhance clozapine usage through biweekly educational sessions over a year. It compares outcomes of those receiving this education against others getting usual treatment without these specific sessions.See study design

What are the potential side effects?

Since the interventions involve educational sessions rather than medical treatments, there are no direct side effects like you'd expect with drugs or surgery. However, participants may experience indirect effects related to changes in practice or workload.

CHAMPION Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 22 and 85 years old.

CHAMPION Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and endpoint changes after 12 month intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and endpoint changes after 12 month intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and endpoint changes after 12 month intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in prescriber knowledge of clozapine use

Change in self-reported competence for clozapine use

Clozapine

CHAMPION Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Education sessionsExperimental Treatment1 Intervention

Project ECHO (Extension for Community Healthcare Outcomes) based intervention sessions for improving the use of clozapine in people with treatment-resistant schizophrenia. The sessions will include: 1) active dissemination of knowledge and information by an expert followed by 2) clozapine case presentations and vignettes.

Group II: No education sessionsPlacebo Group1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor

687 Previous Clinical Trials

374,346 Total Patients Enrolled

66 Trials studying Schizophrenia

9,957 Patients Enrolled for Schizophrenia

Media Library

Clozapine CHAMPION-ECHO Educational Study (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04325386 — N/A

Schizophrenia Research Study Groups: Education sessions, No education sessions

Schizophrenia Clinical Trial 2023: Clozapine CHAMPION-ECHO Educational Study Highlights & Side Effects. Trial Name: NCT04325386 — N/A

Clozapine CHAMPION-ECHO Educational Study (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04325386 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research project actively seeking participants of a certain age or above?

"This medical study necessitates that participants be no younger than 22 and no older than 85, in accordance with the predetermined parameters of inclusion."

Answered by AI

Who is capable of participating in this research investigation?

"Participants hoping to join this clinical trial must possess a diagnosis of schizophrenia and be between the ages 22-85. The study is currently accommodating up to 300 individuals."

Answered by AI

Is recruitment currently open for the trial?

"Contrary to initial expectations, clinicaltrials.gov clearly states thatthis trial is not presently enrolling patients. First posted on February 1st 2020, the study's most recent update was recorded on November 28th 2022. Nevertheless, there are 333 other medical trials actively recruiting participants at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.

Deanna Kelly 2020. "Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04325386.